Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine

被引:15
作者
Son, Ahrum [1 ]
Kim, Woojin [2 ]
Park, Jongham [2 ]
Park, Yongho [2 ]
Lee, Wonseok [2 ]
Lee, Sangwoon [2 ]
Kim, Hyunsoo [2 ,3 ,4 ,5 ]
机构
[1] Scripps Res, Dept Mol Med, San Diego, CA 92037 USA
[2] Chungnam Natl Univ, Dept BioAI Convergence, Daejeon 34134, South Korea
[3] Chungnam Natl Univ, Dept Convergent Biosci & Informat, 99 Daehak Ro, Daejeon 34134, South Korea
[4] Chungnam Natl Univ, Prot AI Design Inst, 99 Daehak Ro, Daejeon 34134, South Korea
[5] SCICS, 99 Daehak Ro, Daejeon 34134, South Korea
基金
新加坡国家研究基金会;
关键词
liquid chromatography-mass spectrometry; clinical chemistry; biomarker discovery; personalized medicine; LIQUID-CHROMATOGRAPHY; ION MOBILITY; PROTEOMICS; QUANTIFICATION; IDENTIFICATION; CHALLENGES;
D O I
10.3390/ijms25189880
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mass spectrometry (MS) has revolutionized clinical chemistry, offering unparalleled capabilities for biomolecule analysis. This review explores the growing significance of mass spectrometry (MS), particularly when coupled with liquid chromatography (LC), in identifying disease biomarkers and quantifying biomolecules for diagnostic and prognostic purposes. The unique advantages of MS in accurately identifying and quantifying diverse molecules have positioned it as a cornerstone in personalized-medicine advancement. MS-based technologies have transformed precision medicine, enabling a comprehensive understanding of disease mechanisms and patient-specific treatment responses. LC-MS has shown exceptional utility in analyzing complex biological matrices, while high-resolution MS has expanded analytical capabilities, allowing the detection of low-abundance molecules and the elucidation of complex biological pathways. The integration of MS with other techniques, such as ion mobility spectrometry, has opened new avenues for biomarker discovery and validation. As we progress toward precision medicine, MS-based technologies will be crucial in addressing the challenges of individualized patient care, driving innovations in disease diagnosis, prognosis, and treatment strategies.
引用
收藏
页数:19
相关论文
共 50 条
[41]   Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform [J].
Eric Schiffer ;
Harald Mischak ;
Dan Theodorescu ;
Antonia Vlahou .
World Journal of Urology, 2008, 26 :67-74
[42]   Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform [J].
Schiffer, Eric ;
Mischak, Harald ;
Theodorescu, Dan ;
Vlahou, Antonia .
WORLD JOURNAL OF UROLOGY, 2008, 26 (01) :67-74
[43]   Mass spectrometry-based tear proteomics for noninvasive biomarker discovery [J].
Ponzini, Erika ;
Santambrogio, Carlo ;
De Palma, Antonella ;
Mauri, Pierluigi ;
Tavazzi, Silvia ;
Grandori, Rita .
MASS SPECTROMETRY REVIEWS, 2022, 41 (05) :842-860
[44]   Advances in High-Resolution Mass Spectrometry-Based Metabolomics: Applications in Food Analysis and Biomarker Discovery [J].
Shang, Wenqi ;
Wei, Guozheng ;
Li, Haibo ;
Zhao, Guohua ;
Wang, Damao .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2025, 73 (06) :3305-3325
[45]   Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery [J].
Issaq, Haleem J. ;
Blonder, Josip .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (13) :1222-1228
[46]   Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery [J].
Doud, Emma H. ;
Yeh, Elizabeth S. .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
[47]   Two-dimensional gel electrophoresis and mass spectrometry for biomarker discovery [J].
Penque, Deborah .
PROTEOMICS CLINICAL APPLICATIONS, 2009, 3 (02) :155-172
[48]   The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics" [J].
Ciocan-Cartita, Cristina Alexandra ;
Jurj, Ancuta ;
Buse, Mihail ;
Gulei, Diana ;
Braicu, Cornelia ;
Raduly, Lajos ;
Cojocneanu, Roxana ;
Pruteanu, Lavinia Lorena ;
Iuga, Cristina Adela ;
Coza, Ovidiu ;
Berindan-Neagoe, Ioana .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
[49]   Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma [J].
Fujii, Kiyonaga ;
Nakamura, Haruhiko ;
Nishimura, Toshihide .
EXPERT REVIEW OF PROTEOMICS, 2017, 14 (04) :373-386
[50]   Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray [J].
Murakoshi, Yusuke ;
Honda, Kazufumi ;
Sasazuki, Shizuka ;
Ono, Masaya ;
Negishi, Ayako ;
Matsubara, Junichi ;
Sakuma, Tomohiro ;
Kuwabara, Hideya ;
Nakamori, Shoji ;
Sata, Naohiro ;
Nagai, Hideo ;
Ioka, Tatsuya ;
Okusaka, Takuji ;
Kosuge, Tomoo ;
Shimahara, Masashi ;
Yasunami, Yohichi ;
Ino, Yoshinori ;
Tsuchida, Akihiko ;
Aoki, Tatsuya ;
Tsugane, Shoichiro ;
Yamada, Tesshi .
CANCER SCIENCE, 2011, 102 (03) :630-638